CAS 1392312-45-6

GSK 3532795

CAS : 1392312-45-6

GSK 3532795 is an investigational antiretroviral compound, which is a synthetic small molecule designed to inhibit HIV-1 capsid function. The source of this compound is GlaxoSmithKline, a pharmaceutical company actively engaged in the development of novel therapeutic agents. GSK 3532795 functions by disrupting the HIV-1 capsid, an essential protein shell that encases the viral RNA and associated enzymes. By targeting this structure, the compound interferes with numerous stages of the viral replication cycle, including disassembly, nuclear import, and encapsidation—thereby effectively inhibiting viral replication.

Formule : C₄₂H₆₂N₂O₄S

Degré de pureté : Min. 95%

Masse moléculaire : 691 g/mol

Ref: 3D-SFC31245

GSK3532795

CAS : 1392312-45-6

GSK3532795: potent oral HIV-1 maturation inhibitor; EC50: 1.9-13 nM for various strains.

Formule : C₄₂H₆₂N₂O₄S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 691.02

Ref: TM-T11494